Velcade IV 3.5 MG

Bortezomib, sold under the brand name Velcade, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment.

Side effects:

• nausea
• diarrhea
• tiredness
• low platelets
• fever
• numbness
• low white blood cells
• shortness of breath
• rash
• abdominal pain
• low blood pressure
• tumour lysis syndrome
• heart failure
• reversible posterior leukoencephalopathy syndrome